Université Libre de Bruxelles' David Venet and his colleagues found that random gene sets can predict breast cancer survival better than published breast cancer signatures, reports Ed Yong at Naturally Selected. "The results may seem unbelievable, but there is a simple reason for them," Yong says.
No Better than Random
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.